 NEW YORK and SAN DIEGO, Aug. 31, 2022 GLOBE NEWSWIRE -- Zentalis Pharmaceuticals, Inc. Nasdaq: ZNTL, a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that Kimberly Blackwell, MD, Chief Executive Officer of Zentalis, will participate in fireside chats at two upcoming investor conferences. 